echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Qilu pharmaceutical holds policy orientation and locks the future in innovation and exploration

    Qilu pharmaceutical holds policy orientation and locks the future in innovation and exploration

    • Last Update: 2017-04-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network enterprise news] from April 10 to 13, Hangzhou held "connecting the future with ideas - 2017 West Lake forum of major health industry and the eighth annual meeting of chain drugstore branch of China Pharmaceutical Materials Association" Qilu Pharmaceutical Co., Ltd was invited to attend the conference In the era of new changes in the industry, Qilu Pharmaceutical Co., Ltd and its pharmaceutical colleagues jointly grasp the pulse of the development of the times and explore the industry opportunities brought by policy advantages Wang Qinggang, vice president of China Pharmaceutical Materials Association and general manager of business zero division of Qilu Pharmaceutical Sales Corporation, explained to the media from the strategic planning of Qilu pharmaceutical, how the enterprise strictly controls the quality of drugs, and how the enterprise attaches importance to scientific research and technology (Qilu pharmaceutical grasps the policy orientation and locks the future in innovation and exploration Picture source: Baidu picture) grasps the policy orientation and win-win DTP market On the evening of November 11, Qilu pharmaceutical · Mou Rong debate - the second pharmaceutical DTP forum attracted a large number of pharmaceutical industry leaders Famous entrepreneurs in the pharmaceutical industry launched friendly sharing and warm discussion here In the critical period of the new medical reform, we see the determination of the national functional departments to eliminate the circulation of drugs and reduce the circulation links The policy guidance and guidance make Chinese medicine people realize that the reform era will not only bring new opportunities, but also meet many challenges under the new situation The emergence of DTP pharmacy has gradually become a hot topic in the industry tracking Song Lianshu, deputy general manager of business zero Business Department of Qilu Pharmaceutical Sales Corporation, was invited to give a keynote speech on "building a new DTP operation mode with the joint efforts of industry and commerce" in this forum He chewed the hidden DTP mode from the perspectives of China's pharmaceutical development process, industry marketing mode, future market forecast, and how China's national conditions can better develop DTP in the industry from a dynamic and related perspective Our predicament and international development track have been well received by the participants In the face of market segmentation, integrated channels continue to develop, Wang Qinggang said: as consumers pay more attention to the quality and efficacy of products, for industrial enterprises, high-value brand goods bring not only sales promotion, but also the inheritance of corporate brand culture Continuous innovation of high-tech products is the foundation of enterprise progress Any enterprise needs to obtain more market resources and win more in-depth strong cooperation with the continuous updating of products Qilu people have long been committed to planning the firm foothold of the enterprise from the perspective of the future According to the expected changes of the short, medium and long-term market, Qilu will subdivide the target market, and prioritize Qilu will start with high-tech products, and strive to build the brand pioneer of Qilu pharmaceutical The participants highly recognized the future development of Qilu pharmaceutical, and the market was full of expectations for the future of Qilu pharmaceutical Qilu people will challenge one strategic high point after another under the leadership of the company's decision-makers With the support of policies and the expectation of the industry, Qilu people will move forward bravely! Lock the future in innovation and exploration Under the leadership of general manager Wang Qinggang, the business zero division of Qilu Pharmaceutical Sales Corporation continues the frontier exploration of terminal prescription sales, the steady operation of team integration, and highlights the industry In the West Lake forum, Qilu pharmaceutical won two awards: "VIP Strategic Cooperation Award of chain drugstores of China Pharmaceutical Materials Association" and "five year contribution of West Lake forum" Its DINK series products have a solid market foundation and won the reputation of "pharmaceutical Internet potential products" According to the 2016-2017 Chinese drugstore e-commerce report, the drug e-commerce restrained by the policy of banning the sale of drugs on the third-party network platform is on the rise against the trend The demand and repurchase rate of qiludink series products for online drug purchase are also increasing, forming a benign complementarity between online and offline Communication promotes win-win results During the exhibition, Qilu pharmaceutical brand exhibition area attracted numerous customers to negotiate Wang Qinggang, general manager of business zero Business Department of Qilu pharmaceutical sales company, and his team conducted in-depth communication with the guests Participants said: Qilu pharmaceutical adheres to the commercial civilization with innovation as the driving force, quality as the foundation and market as the core, showing the development strength of mature enterprises.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.